Progress of Integrated Medicine in the Treatment of Androgenic Alopecia

January 2016

Sun Wen, Gao-Wen Yang, Chen Yujia, Liu Hongru, Deng Wanying, Huang Shu-hong, Cha Xvshan, Liu Jing

androgenic alopecia androgen signaling pathways antiandrogen therapy sexual dysfunction Traditional Chinese Medicine syndrome differentiation AGA TCM

TLDR Traditional Chinese Medicine, combined with antiandrogen therapy, could improve treatment and reduce side effects for genetic hair loss.

The 2016 study "Progress of Integrated Medicine in the Treatment of Androgenic Alopecia" discussed the role of androgen signaling pathways in the pathogenesis of Androgenic Alopecia (AGA), a common genetic hair loss disease. The study highlighted the effectiveness of antiandrogen therapy, but also noted its limitations due to adverse reactions like sexual dysfunction. The authors suggested that Traditional Chinese Medicine (TCM), guided by the theory of "syndrome differentiation", could offer unique benefits in enhancing the efficacy of treatment, consolidating curative effects, and reducing side effects. The paper aimed to introduce new perspectives from both TCM and western medicine for clinical diagnosis and treatment of AGA.

View this study on caod.oriprobe.com →

Discuss this study in the Community →

Related Research

12 / 12 results

research Non-Surgical Options to Treat Androgenic Alopecia

November 2021 in “World Family Medicine Journal /Middle East Journal of Family Medicine”

Minoxidil, Finasteride, and low-level laser therapy can help manage hair loss.

research Alopecia Types, Current and Future Treatment

3 citations, January 2021 in “Journal of dermatology & cosmetology”

Current alopecia treatments manage symptoms but don't cure, and better treatments are needed.

research New Drugs Under Investigation for the Treatment of Alopecias

26 citations, January 2019 in “Expert Opinion on Investigational Drugs”

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

research Off-Label Use of Topical Minoxidil in Alopecia: A Review

32 citations, January 2019 in “American Journal of Clinical Dermatology”

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

research Modern Approaches to the Therapy of Androgenic Alopecia

1 citations, January 2019 in “Klinicheskaya dermatologiya i venerologiya”

research Assessing the Quality of Life and Health Outcomes of Androgenic Alopecia Patients Using Propecia

January 2016

Propecia users with Androgenic Alopecia experienced a lower quality of life and more serious side effects compared to those using Minoxidil.

research Treatment Options for Alopecia

17 citations, August 2015 in “Expert Opinion on Pharmacotherapy”

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

research Treatment Strategies for Alopecia

34 citations, April 2009 in “Expert Opinion on Pharmacotherapy”

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

research Androgenetic Alopecia and Quality of Life

September 2000 in “PubMed”

research Management of Androgenetic Alopecia

22 citations, May 2000 in “American Journal of Clinical Dermatology”

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

research Hair Restoration Surgery

January 2000 in “Springer eBooks”

research Chapter 40: Surgical Treatment of Androgenetic Alopecia

January 1990

Progress of Integrated Medicine in the Treatment of Androgenic Alopecia

Related Community Posts Join

community Testosterone and hair loss seeming irrelevance

community So we have 20k dollars human like machines available but no new effective treatment for hairloss since finasteride :)

community I started rapidly diffuse thinning at 22. I'm 42 now and have as much hair as I did at 16. AMA

community Maintaining hair until Breezula without Fin

community Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China

community PYRILUTAMIDE PHASE 3 RESULTS : No statistical significance